WallStSmart

Alignment Healthcare LLC (ALHC)vsElevance Health Inc (ELV)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Elevance Health Inc generates 4624% more annual revenue ($201.11B vs $4.26B). ELV leads profitability with a 2.5% profit margin vs 0.5%. ELV trades at a lower P/E of 16.9x. ELV earns a higher WallStSmart Score of 55/100 (C-).

ALHC

Hold

45

out of 100

Grade: D+

Growth: 8.0Profit: 4.5Value: 4.3Quality: 6.0
Piotroski: 4/9Altman Z: 2.95

ELV

Buy

55

out of 100

Grade: C-

Growth: 4.0Profit: 5.0Value: 6.7Quality: 6.5
Piotroski: 4/9Altman Z: 2.66
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ALHCUndervalued (+4.6%)

Margin of Safety

+4.6%

Fair Value

$21.37

Current Price

$18.29

$3.08 discount

UndervaluedFair: $21.37Overvalued
ELVUndervalued (+7.5%)

Margin of Safety

+7.5%

Fair Value

$416.99

Current Price

$385.73

$31.26 discount

UndervaluedFair: $416.99Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ALHC1 strengths · Avg: 10.0/10
Revenue GrowthGrowth
33.3%10/10

Revenue surging 33.3% year-over-year

ELV4 strengths · Avg: 8.3/10
Market CapQuality
$85.33B9/10

Large-cap with strong market position

P/E RatioValuation
16.9x8/10

Attractively priced relative to earnings

Price/BookValuation
1.9x8/10

Reasonable price relative to book value

Free Cash FlowQuality
$1.63B8/10

Generating 1.6B in free cash flow

Areas to Watch

ALHC4 concerns · Avg: 3.5/10
Price/BookValuation
18.3x4/10

Trading at 18.3x book value

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Profit MarginProfitability
0.5%3/10

0.5% margin — thin

Operating MarginProfitability
1.3%3/10

Operating margin of 1.3%

ELV4 concerns · Avg: 3.0/10
Revenue GrowthGrowth
1.4%4/10

1.4% revenue growth

Profit MarginProfitability
2.5%3/10

2.5% margin — thin

Operating MarginProfitability
4.6%3/10

Operating margin of 4.6%

EPS GrowthGrowth
-13.1%2/10

Earnings declined 13.1%

Comparative Analysis Report

WallStSmart Research

Bull Case : ALHC

The strongest argument for ALHC centers on Revenue Growth. Revenue growth of 33.3% demonstrates continued momentum.

Bull Case : ELV

The strongest argument for ELV centers on Market Cap, P/E Ratio, Price/Book. PEG of 1.35 suggests the stock is reasonably priced for its growth.

Bear Case : ALHC

The primary concerns for ALHC are Price/Book, EPS Growth, Profit Margin. A P/E of 206.0x leaves little room for execution misses. Debt-to-equity of 1.59 is elevated, increasing financial risk.

Bear Case : ELV

The primary concerns for ELV are Revenue Growth, Profit Margin, Operating Margin. Thin 2.5% margins leave little buffer for downturns.

Key Dynamics to Monitor

ALHC profiles as a hypergrowth stock while ELV is a value play — different risk/reward profiles.

ALHC carries more volatility with a beta of 1.05 — expect wider price swings.

ALHC is growing revenue faster at 33.3% — sustainability is the question.

ELV generates stronger free cash flow (1.6B), providing more financial flexibility.

Bottom Line

ELV scores higher overall (55/100 vs 45/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Alignment Healthcare LLC

HEALTHCARE · HEALTHCARE PLANS · USA

Alignment Healthcare, Inc. provides a consumer-centric platform that provides personalized healthcare to seniors in the United States. The company is headquartered in Orange, California.

Elevance Health Inc

HEALTHCARE · HEALTHCARE PLANS · USA

Elevance Health Inc. is a health benefits company. The company is headquartered in Indianapolis, Indiana.

Want to dig deeper into these stocks?